Table S7 from Microbial Metabolic Pathways Guide Response to Immune Checkpoint Blockade Therapy

2026 Open access

Read full text
Authors: Iris L. Mimpen, Thomas Battaglia, Miguel Parra-Martinez, Catherine Toner-Bartelds, Laurien Joanna Zeverijn, Birgit S. Geurts, Karlijn Verkerk, Louisa Rose Hoes, Allard W. J. van Renterghem, Michaël Noë, Ingrid Hofland, Annegien Broeks
+10 more Vincent van der Noort, Edwin C.A. Stigter, Can M.C. Gulersonmez, Boudewijn M.T. Burgering, Merel van Gogh, Marcel R. de Zoete, Hans A. J. Gelderblom, Krijn Kristian Dijkstra, Lodewyk F.A. Wessels, Emile E. Voest
DOI: 10.1158/2159-8290.31047145
Cited by: 0

Abstract

Clinical characteristics of all MSI patients from different ICB-treated cohorts within DRUP.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Gut microbiota and health T-cell and B-cell Immunology

Publication details

Publication date
12 January 2026